10 Stomach Cancer Clinical Trials in Duarte, CA (2026)

Q: How do I join a clinical trial in Duarte?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Duarte research site will contact you.

Recruiting Stomach Cancer Studies in Duarte

NCT07431281Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

The purpose of this study is to evaluate the efficacy and safety of sonesitatug vedotin in combination with capecitabine with or without rilvegostomig in first-line (1L) Claudin18.2 (CLDN18.2)-positiv...

Duarte, CAPHASE32,130 participantsAstraZeneca

View Study Details

NCT06764875Recruiting

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

This is a Phase Ⅲ, randomized, open-label, Sponsor-blinded, 3-arm, global, multicenter study assessing the efficacy and safety of rilvegostomig in combination with fluoropyrimidine and T-DXd (Arm A) c...

Duarte, CAPHASE3840 participantsAstraZeneca

View Study Details

NCT07243015Recruiting

Detection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis Markers

Gastric cancer (GC) is a leading cause of cancer-related death worldwide. Even in patients undergoing curative surgery for non-metastatic disease, postoperative recurrence frequently occurs due to und...

Duarte, CA500 participantsCity of Hope Medical Center

View Study Details

NCT07587229Recruiting

Alternative Splicing Based Prediction of Chemotherapy Response in Gastric Cancer

This study aims to develop a model to predict response to chemotherapy in gastric cancer using RNA splicing information from tumor tissue. By analyzing genetic patterns and applying machine learning,...

Duarte, CA329 participantsCity of Hope Medical Center

View Study Details

NCT05482893Recruiting

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

This is a first-in-human, Phase 1/2, open-label, dose escalation and dose expansion and combination study designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and prelimi...

Duarte, CAPHASE1258 participantsPhanes Therapeutics

View Study Details

NCT06408220Recruiting

Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer

This clinical trial evaluates the usefulness of various risk assessment tests, including Helicobacter pylori (H. pylori) breath testing, questionnaires, and endoscopies for identifying participants at...

Duarte, CANA240 participantsCity of Hope Medical Center

View Study Details

NCT06628310Recruiting

A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess adverse events and change in disease activity when ABBV-400 is gi...

Duarte, CAPHASE2180 participantsAbbVie

View Study Details

NCT06038578Recruiting

A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

This study will assess the efficacy, safety, optimal dose and ADA and NAbs development of TRK-950 at two separate dose levels in combination with ramucirumab and paclitaxel (RAM+PTX) as compared with ...

Duarte, CAPHASE2146 participantsToray Industries, Inc

View Study Details

NCT04329494Recruiting

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

This phase I trial studies the side effects of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in treating patients with ovarian, uterine, appendiceal, stomach (gastric), or colorectal cancer...

Duarte, CAPHASE149 participantsCity of Hope Medical Center

View Study Details

NCT06675136Recruiting

Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases

This phase I trial tests the safety, side effects and best dose of nab-paclitaxel pressurized intraperitoneal aerosolized chemotherapy (PIPAC) in combination with second-line chemotherapy, paclitaxel ...

Duarte, CAPHASE130 participantsCity of Hope Medical Center

View Study Details

About Stomach Cancer Clinical Trials in Duarte

Stomach (gastric) cancer develops in the lining of the stomach and is more common in certain regions of the world. Risk factors include H. pylori infection, smoking, and diet. Treatment includes surgery, chemotherapy, radiation, and immunotherapy.

There are currently 10 stomach cancer clinical trials recruiting participants in Duarte, CA. These studies are seeking a combined 4,702 participants. Research is being sponsored by AstraZeneca, City of Hope Medical Center, Phanes Therapeutics and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Stomach Cancer Clinical Trials in Duarte — FAQ

Are there stomach cancer clinical trials in Duarte?

Yes, there are 10 stomach cancer clinical trials currently recruiting in Duarte, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Duarte?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Duarte research site will contact you about next steps.

Are clinical trials in Duarte free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Duarte studies also compensate for your time and travel.

What stomach cancer treatments are being tested?

The 10 active trials in Duarte are testing new therapies including novel drugs, biologics, and treatment approaches for stomach cancer.

Data updated July 19, 2026 from ClinicalTrials.gov